Martin J. Hughes

Keine laufenden Positionen mehr

Health Technology

Electronic Technology

Consumer Services

Ehemalige bekannte Positionen von Martin J. Hughes

Unternehmen	Position	Beginn	Ende
Microscience Ltd. Microscience Ltd. Pharmaceuticals: MajorHealth Technology Microscience is an emerging vaccine company which is primarily involved in the discovery and development of innovative, rationally designed vaccines and immunotherapeutics for the prevention and treatment of disease in areas that the Company believes to represent a significant opportunity for new vaccines	Corporate Officer/Principal	-	-
F2G Ltd. F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom.	Corporate Officer/Principal	01.01.2002	-
Myconostica Ltd. Myconostica Ltd. Electronic Equipment/InstrumentsElectronic Technology Myconostica Ltd. developed molecular diagnostic fungal testing kits. The company was founded in February 2006 and is headquartered in Cambridge, the United Kingdom.	Technik-/Wissenschafts-/F&E-Leiter	01.04.2008	-
	General Counsel	01.04.2008	-

The University of Nottingham

Doctorate Degree

International

Vereinigtes Königreich

Operativ

Corporate Officer/Principal	2
Chief Tech/Sci/R&D Officer	1
General Counsel	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	3
Myconostica Ltd. Myconostica Ltd. Electronic Equipment/InstrumentsElectronic Technology Myconostica Ltd. developed molecular diagnostic fungal testing kits. The company was founded in February 2006 and is headquartered in Cambridge, the United Kingdom.	Electronic Technology
Microscience Ltd. Microscience Ltd. Pharmaceuticals: MajorHealth Technology Microscience is an emerging vaccine company which is primarily involved in the discovery and development of innovative, rationally designed vaccines and immunotherapeutics for the prevention and treatment of disease in areas that the Company believes to represent a significant opportunity for new vaccines	Health Technology
F2G Ltd. F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom.	Health Technology